According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings (TTM) are HK$35.75 B. In 2023 the company made an earning of HK$32.73 B a decrease over its 2022 earnings that were of HK$37.87 B.The earnings displayed on this page is the company's Pretax Income.